Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Pre-Tax Margin

IONIS PHARMACEUTICALS INC Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • IONIS PHARMACEUTICALS INC pre-tax margin for the quarter ending 2017-09-30 was -3.25%, a 149.11% decline year-over-year.
  • IONIS PHARMACEUTICALS INC pre-tax margin for the quarter ending 2017-06-30 was -10.55%, a change of 137.84% year-over-year.
  • IONIS PHARMACEUTICALS INC pre-tax margin for the quarter ending 2017-03-31 was 3.14%, a change of 173.14% year-over-year.
  • IONIS PHARMACEUTICALS INC pre-tax margin for the quarter ending 2016-12-31 was 17.96%, a change of 155.75% year-over-year.
  • IONIS PHARMACEUTICALS INC pre-tax margin for fiscal 2025 was -40.22%, a change of 25.02% from fiscal 2024.
  • IONIS PHARMACEUTICALS INC pre-tax margin for fiscal 2024 was -65.25%, a change of -22.84% from fiscal 2023.
  • IONIS PHARMACEUTICALS INC pre-tax margin for fiscal 2023 was -42.40%, a change of 1.52% from fiscal 2022.
  • IONIS PHARMACEUTICALS INC pre-tax margin for fiscal 2022 was -43.92%, a change of -40.33% from fiscal 2021.
Available history
2010-09-30 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2017-09-30-3.25%-$3.94M$120.91M
2017-06-30-10.55%-$10.98M$104.15M
2017-03-313.14%$3.47M$110.3M
2016-12-3117.96%$28.8M$160.35M
2016-09-306.63%$7.35M$110.93M
2016-06-30-148.39%-$57.09M$38.47M
2016-03-31-170.00%-$62.69M$36.87M
2015-12-31-137.80%-$71.06M$51.57M
2015-09-30-72.83%-$35.78M$49.12M
2015-06-3030.26%$36.44M$120.43M
2015-03-31-27.97%-$17.51M$62.58M
2014-12-3118.43%$15.64M$84.86M
2014-09-30-57.37%-$25.28M$44.06M
2014-06-30-19.62%-$11.2M$57.08M
2014-03-31-119.16%-$33.56M$28.16M
2013-12-31-56.22%-$23.75M$42.25M
2013-09-30-126.19%-$29.76M$23.59M
2013-06-30-29.68%-$11.31M$38.09M
2013-03-31-4.00%-$1.74M$43.36M
2012-12-31-55.56%-$11.04M$19.87M
2012-09-30-330.53%-$38.35M$11.6M
2012-06-30-2.55%-$1.21M$47.34M
2012-03-31-103.26%-$23.99M$23.24M
2011-12-31-61.83%-$20.04M$32.4M
2011-09-30-129.78%-$26.88M$20.71M
2011-06-30-72.03%-$17.88M$24.82M
2011-03-31-94.54%-$19.99M$21.15M
2010-12-31-52.60%-$13.9M$26.42M
2010-09-30-43.51%-$12.45M$28.62M

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-31-40.22%-$379.6M$943.71M
2024-12-31-65.25%-$460.07M$705.14M
2023-12-31-42.40%-$333.97M$787.65M
2022-12-31-43.92%-$257.99M$587.37M
2021-12-31-3.60%-$29.15M$810.46M
2020-12-31-18.45%-$134.55M$729.26M
2019-12-3130.18%$338.77M$1.12B
2016-12-31-22.43%-$83.62M$372.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10